Danaher Corporation (0R2B.L)
USD 230.79
(-1.77%)
USD 230.79
(-1.77%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 84.48 Billion USD | 0.16% |
| 2022 | 84.35 Billion USD | 1.4% |
| 2021 | 83.18 Billion USD | 9.22% |
| 2020 | 76.16 Billion USD | 22.68% |
| 2019 | 62.08 Billion USD | 29.79% |
| 2018 | 47.83 Billion USD | 2.54% |
| 2017 | 46.64 Billion USD | 2.99% |
| 2016 | 45.29 Billion USD | -6.07% |
| 2015 | 48.22 Billion USD | 30.36% |
| 2014 | 36.99 Billion USD | 6.69% |
| 2013 | 34.67 Billion USD | 5.26% |
| 2012 | 32.94 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 80.61 Billion USD | 2.62% |
| 2024 Q2 | 78.55 Billion USD | -5.81% |
| 2024 Q1 | 83.4 Billion USD | -1.29% |
| 2023 Q2 | 84.9 Billion USD | -0.16% |
| 2023 FY | 84.48 Billion USD | 0.16% |
| 2023 Q4 | 84.48 Billion USD | -3.7% |
| 2023 Q1 | 85.04 Billion USD | 0.82% |
| 2023 Q3 | 87.73 Billion USD | 3.34% |
| 2022 Q4 | 84.35 Billion USD | 4.1% |
| 2022 FY | 84.35 Billion USD | 1.4% |
| 2022 Q3 | 81.03 Billion USD | -0.95% |
| 2022 Q2 | 81.8 Billion USD | -1.9% |
| 2022 Q1 | 83.39 Billion USD | 0.25% |
| 2021 Q1 | 75.42 Billion USD | -0.97% |
| 2021 FY | 83.18 Billion USD | 9.22% |
| 2021 Q3 | 82.49 Billion USD | 5.73% |
| 2021 Q4 | 83.18 Billion USD | 0.83% |
| 2021 Q2 | 78.02 Billion USD | 3.45% |
| 2020 Q1 | 68.93 Billion USD | 11.03% |
| 2020 Q3 | 72.89 Billion USD | 2.28% |
| 2020 FY | 76.16 Billion USD | 22.68% |
| 2020 Q4 | 76.16 Billion USD | 4.49% |
| 2020 Q2 | 71.26 Billion USD | 3.39% |
| 2019 Q1 | 51.77 Billion USD | 8.24% |
| 2019 FY | 62.08 Billion USD | 29.79% |
| 2019 Q4 | 62.08 Billion USD | 0.9% |
| 2019 Q3 | 61.53 Billion USD | 15.4% |
| 2019 Q2 | 53.32 Billion USD | 2.99% |
| 2018 Q4 | 47.83 Billion USD | 0.24% |
| 2018 Q2 | 48.05 Billion USD | 1.93% |
| 2018 Q1 | 47.14 Billion USD | 1.06% |
| 2018 FY | 47.83 Billion USD | 2.54% |
| 2018 Q3 | 47.71 Billion USD | -0.7% |
| 2017 Q2 | 45.64 Billion USD | 0.89% |
| 2017 FY | 46.64 Billion USD | 2.99% |
| 2017 Q1 | 45.24 Billion USD | -0.11% |
| 2017 Q3 | 45.85 Billion USD | 0.45% |
| 2017 Q4 | 46.64 Billion USD | 1.74% |
| 2016 Q1 | 48.38 Billion USD | 0.34% |
| 2016 FY | 45.29 Billion USD | -6.07% |
| 2016 Q3 | 41.29 Billion USD | -19.82% |
| 2016 Q4 | 45.29 Billion USD | 9.68% |
| 2016 Q2 | 51.5 Billion USD | 6.44% |
| 2015 Q4 | 48.22 Billion USD | -2.99% |
| 2015 Q1 | 36.07 Billion USD | -2.49% |
| 2015 Q3 | 49.7 Billion USD | 34.39% |
| 2015 Q2 | 36.98 Billion USD | 2.54% |
| 2015 FY | 48.22 Billion USD | 30.36% |
| 2014 Q4 | 36.99 Billion USD | 4.1% |
| 2014 Q3 | 35.53 Billion USD | -0.33% |
| 2014 Q2 | 35.65 Billion USD | 1.74% |
| 2014 Q1 | 35.04 Billion USD | 1.07% |
| 2014 FY | 36.99 Billion USD | 6.69% |
| 2013 FY | 34.67 Billion USD | 5.26% |
| 2013 Q1 | 32.46 Billion USD | -1.43% |
| 2013 Q4 | 34.67 Billion USD | 2.82% |
| 2013 Q2 | 33.1 Billion USD | 1.97% |
| 2013 Q3 | 33.72 Billion USD | 1.85% |
| 2012 Q4 | 32.94 Billion USD | 0.0% |
| 2012 FY | 32.94 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -22667.829% |
| Accuray Incorporated | 468.62 Million USD | -17928.837% |
| Align Technology, Inc. | 6.08 Billion USD | -1288.72% |
| Elevance Health Inc. | 108.92 Billion USD | 22.437% |
| AxoGen, Inc. | 196.82 Million USD | -42825.005% |
| Boston Scientific Corporation | 35.13 Billion USD | -140.46% |
| CVS Health Corporation | 249.72 Billion USD | 66.168% |
| Cardinal Health, Inc. | 45.12 Billion USD | -87.248% |
| Centene Corporation | 84.64 Billion USD | 0.181% |
| DaVita Inc. | 17.61 Billion USD | -379.515% |
| HCA Healthcare, Inc. | 56.21 Billion USD | -50.305% |
| Hologic, Inc. | 9.15 Billion USD | -822.761% |
| Humana Inc. | 47.06 Billion USD | -79.513% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -2491.716% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -405.157% |
| Masimo Corporation | 3.04 Billion USD | -2677.84% |
| McKesson Corporation | 67.44 Billion USD | -25.273% |
| Patterson Companies, Inc. | 2.96 Billion USD | -2745.613% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -502.539% |
| ResMed Inc. | 6.87 Billion USD | -1129.382% |
| Henry Schein, Inc. | 10.57 Billion USD | -699.092% |
| Teladoc Health, Inc. | 4.39 Billion USD | -1823.518% |
| Universal Health Services, Inc. | 14.35 Billion USD | -488.486% |
| Veeva Systems Inc. | 5.91 Billion USD | -1329.354% |
| Baxter International Inc. | 28.27 Billion USD | -198.798% |
| Becton, Dickinson and Company | 52.78 Billion USD | -60.076% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -447.149% |
| Stryker Corporation | 39.91 Billion USD | -111.686% |
| Medtronic plc | 89.98 Billion USD | 6.105% |